Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Chubb
US Department of Justice
Express Scripts
Teva
Harvard Business School
Merck
Johnson and Johnson
Accenture

Generated: January 17, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Evogliptin

« Back to Dashboard

US Patents for Evogliptin

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Evogliptin ➤ Try a Free Trial DPP-IV inhibitor including beta-amino group, preparation method thereof and pharmaceutical composition containing the same for preventing and treating diabetes or obesity Dong-A Pharm. Co., Ltd. (Seoul, KR) ➤ Try a Free Trial
Evogliptin ➤ Try a Free Trial Pharmaceutical composition for prevention and treatment of diabetes or obesity comprising a compound that inhibits activity of dipeptidyl peptidase-IV, and other antidiabetic or antiobesity agents as active ingredients Dong-A Pharmaceutical Co. Ltd. (Seoul, KR) ➤ Try a Free Trial
Evogliptin ➤ Try a Free Trial Method for manufacturing dipeptidyl peptidase-IV inhibitor and intermediate Dong-A Pharmaceutical. Co., Ltd (Seoul, KR) ➤ Try a Free Trial
Evogliptin ➤ Try a Free Trial Method for preparing dipeptidyl peptidase-IV inhibitor and intermediate DONG-A PHARMACEUTICAL CO., LTD. (Seoul, KR) ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Evogliptin

Drugname Country Document Number Estimated Expiration Related US Patent
Evogliptin Australia 2008241692 2027-04-19 ➤ Try a Free Trial
Evogliptin Brazil PI0810246 2027-04-19 ➤ Try a Free Trial
Evogliptin Canada 2683696 2027-04-19 ➤ Try a Free Trial
Evogliptin China 101663282 2027-04-19 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Dow
Daiichi Sankyo
Queensland Health
Merck
UBS
Medtronic
Deloitte
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.